Figure 3
Figure 3. p53ERTAM stability in Mdm2-and Arf-overexpressing cells. (A) Immunoblotting detecting p53ERTAM in cycloheximide (CHX)–treated Mp53ERRES cells in the absence (left panel) and the presence (right panel) of 4OHT. (B) Immunoblotting detecting Arf in Mp53ERRES cells infected with the control (“vector”) and the Arf-transducing (“Arf”) retroviruses. (C) Immunoblotting detecting p53ERTAM in the same cultures. Where indicated, cells were pretreated with 4OHT for 3 hours. (D) Selection against Arf-overexpressing Mp53ERRES cells in mixed cultures. When indicated, 4OHT was added on day 2 after infection.

p53ERTAM stability in Mdm2-and Arf-overexpressing cells. (A) Immunoblotting detecting p53ERTAM in cycloheximide (CHX)–treated Mp53ERRES cells in the absence (left panel) and the presence (right panel) of 4OHT. (B) Immunoblotting detecting Arf in Mp53ERRES cells infected with the control (“vector”) and the Arf-transducing (“Arf”) retroviruses. (C) Immunoblotting detecting p53ERTAM in the same cultures. Where indicated, cells were pretreated with 4OHT for 3 hours. (D) Selection against Arf-overexpressing Mp53ERRES cells in mixed cultures. When indicated, 4OHT was added on day 2 after infection.

Close Modal

or Create an Account

Close Modal
Close Modal